Loading...
HomeMy WebLinkAboutThe Times Advocate, 2004-11-17, Page 16Crossroads 16 Wednesday, Nov 17, 2004 Exeter Times Advocate Groundbreaking study involves Exeter doctors By Pat Bolen TIMES -ADVOCATE STAFF EXETER — Two Exeter doctors are involved in a ground- breaking study on pre- venting heart disease in people with normal cholesterol levels and no previous history of heart disease. Doctors Jerome Jadd and Krista Fatum are part of the Jupiter Study, which over the next few years will study around 15,000 people to see if choles- terol lowering medica- tions (statins) in men and women with raised levels of C-reactive pro- tein (CRP) but with nor- mal levels of LDL-cho- lesterol (bad choles- terol) and no apparent cardiovascular disease. The study was origi- nated by Dr. Paul Ridker, professor of Medicine at Harvard Medical School and director of the centre for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Boston, who was named by Time magazine this year as one of the 100 most influential people in the world. Ridker has been a pioneer in studying one of the biggest mysteries of heart disease which is if cholesterol is one of the major contribu- tors to heart disease, why do half of all heart attacks occur in people with normal cholesterol levels? For the past 10 years Ridker has looked at a link between the infec- tion fighting immune system of the body and heart disease with the key possibly being the inflammation process by which the body defends itself. Just as when immune cells are released when viruses attack the body, the same process occurs when fat builds up in plaques in heart vessels. Ridker measures inflammation with a specific indicator of the process, which is CRP. CRP can be measured and is a reliable indica- tor of how much inflammation is occur- ring in the heart and how likely a heart attack may be. Jadd said the study may change the approach to heart dis- ease treatment. "It is the most excit- ing study I've ever been involved in, with hun- dreds of thousands of lives in the balance." According to Jadd, the study will involve healthy people whose only risk is elevated CRP. Half of the patients will be placed on CRP Crestor and half will be 011 placebos. Crestor is not an experimental drug and has already been approved for sale in North America. Study organizers will have 500 to 600 sites across North America and are hoping to have around 30 patients at each site. Jadd said while heart disease studies are nor- mally done in cardiolo- gists' offices, they don't see healthy patients, which is why the study is being done at the family practice level. The study will last between three and half and five years. Jadd said he believes it is unprecedented for its size, with a normal large study involving 4000 people and a small study 400. Organizers are look- ing for men 55 or older and women 65 or older with no history of heart attack or stroke. The reason for the age, according to Jadd, is patients are entering high risk levels times, cutting down on the time needed to do the study, compared to having participants who are younger and may not develop symp- toms for several years. Exeter doctors Krista Fatum and Jerome Jadd are involved in a study looking at new ways to treat heart disease. (photo/PatBolen) Those wishing to par- ticipate in the study will undergo initial screening visits to determine their eligibil- ity. If selected they will be required to make two brief clinic visits per year for up to four years. They will also be required to take one study pill per day for up to four years. Jadd said patients are interested in the study and there has been a good response for par- ticipating. New audiology services open at Gill Road Health Centre GRAND BEND — A new service has opened in the former medical clinic facility on Gill Road operated by the Grand Bend Area Community Health Centre. Hearing Health Services, Grand Bend will be open Wednesdays each week to offer an audiology clinic for area residents. The building has been renovat- ed to accommodate a range of sophisticated new equipment and testing facilities. Johann Pinto, a Critical Audiologist based at St. Joseph's Health Care, London is one of the special- ists who will be visiting the facility regularly. "We are very pleased to offer this new service in the Grand Bend area," he said. "Many of our clients live in this area, and their family doctors have referred them to us in London. Now we can provide the service closer to home." Nose and throat specialists will also visit the facil- ity, based on demand and patient referrals by their doctor. Bill Carr of Carr Hearing Services will also work at the clinic, offering not only hearing aids but assisted hearing devices for help in hearing the doorbell, televisions, etc. Carr explains their service includes an education- al approach to hearing loss that involves the patients and their family, explains the use of hear- ing aids and assists in rehabilitation. The clinic's services are largely covered by OHIP. They are provided based on referral by a doctor, but Carr notes a referral can likely be obtained by contacting the clinic directly if someone does not have a family doctor in the area. For further information, contact: Ann Joe - McInnis, Manager, Hearing Health Services, Grand Bend at 473 3700 or Dan Steinwald, Executive Director, Grand Bend Area Community Health Centre at 238-1556 ext. 1. Hearing Health Services, Grand Bend staff, top: Johann Pinto, Critical Audiologist; Bill Carr, Hearing Aid Dispenser; Ann Joe -McInnis, Manager; Helen Exley, Hearing Aid Specialist. Bottom: Lori DiMarco, Nurse; Barb McLeod, Computer Technologist and Vicki Emery, Secretary/Receptionist. (photo/submitted)